BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37884763)

  • 21. Distinction of Lymphoma from Sarcoidosis on
    Lovinfosse P; Ferreira M; Withofs N; Jadoul A; Derwael C; Frix AN; Guiot J; Bernard C; Diep AN; Donneau AF; Lejeune M; Bonnet C; Vos W; Meyer PE; Hustinx R
    J Nucl Med; 2022 Dec; 63(12):1933-1940. PubMed ID: 35589406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stacking Ensemble Learning-Based [
    Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M
    J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of
    Michaud L; Bantilan K; Mauguen A; Moskowitz CH; Zelenetz AD; Schöder H
    J Nucl Med; 2023 Apr; 64(4):536-541. PubMed ID: 36549918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [
    Travaini LL; Botta F; Derenzini E; Lo Presti G; Ferrari ME; Airò Farulla LS; Radice T; Mazzara S; Tarella C; Pileri S; Raimondi S; Ceci F
    Hematol Oncol; 2023 Oct; 41(4):674-682. PubMed ID: 37209024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumor Heterogeneity Assessed by
    Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
    Acad Radiol; 2020 Aug; 27(8):e183-e192. PubMed ID: 31761665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of
    Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review.
    Frood R; Burton C; Tsoumpas C; Frangi AF; Gleeson F; Patel C; Scarsbrook A
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3198-3220. PubMed ID: 33604689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of body composition and metabolic parameters extracted from baseline
    Chen Y; Chen Z; Tan X; Zhang Q; Zhou Y; Yuan H; Jiang L
    Ann Hematol; 2023 Oct; 102(10):2779-2789. PubMed ID: 37530853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic Value of
    Su JM; Zheng QZ; Huang WR; Deng J; Wu J; Lu HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1181-1186. PubMed ID: 34362500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of
    Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J
    Ann Nucl Med; 2020 Dec; 34(12):911-919. PubMed ID: 33057996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Impact of Pretreatment 2-[
    Albano D; Dondi F; Mazzoletti A; Bellini P; Giubbini R; Bertagna F
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34069203
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic value of
    Ying Z; Mi L; Zhou N; Wang X; Yang Z; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Zhang C; Liu W; Deng L; Zhu J
    Chin J Cancer Res; 2019 Feb; 31(1):162-170. PubMed ID: 30996574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Overall Survival and Progression-Free Survival by the
    Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
    Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
    [No Abstract]   [Full Text] [Related]  

  • 36. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings.
    Kong Y; Qu L; Li Y; Liu D; Lv X; Han J
    Medicine (Baltimore); 2016 Feb; 95(6):e2808. PubMed ID: 26871850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma.
    Yousefirizi F; Gowdy C; Klyuzhin IS; Sabouri M; Tonseth P; Hayden AR; Wilson D; Sehn LH; Scott DW; Steidl C; Savage KJ; Uribe CF; Rahmim A
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Values of Different Evaluation Criteria of Interim
    Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of therapeutic effect and prognostic value of
    Zhao W; Wu X; Huang S; Wang H; Fu H
    EJNMMI Res; 2024 Feb; 14(1):20. PubMed ID: 38372908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.